Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cameron Sullards

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Applied and Environmental Microbiology|September 15, 2009
Rapid identification of Vibrio parahaemolyticus by whole-cell matrix-assisted laser desorption ionization-time of flight mass spectrometryTracy H Hazen, Robert J Martinez, Yanfeng Chen, et al.
The Journal of Biological Chemistry|September 30, 2010
Kdo2-lipid A, a TLR4-specific agonist, induces de novo sphingolipid biosynthesis in RAW264.7 macrophages, which is essential for induction of autophagyKacee Sims, Christopher A Haynes, Samuel Kelly, et al.
The Journal of Biological Chemistry|March 7, 2006
Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseasesJoungil Choi, M Cameron Sullards, James A Olzmann, et al.
Molecular Cancer|July 14, 2010
Elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometryYing Liu, Yanfeng Chen, Amin Momin, et al.
Molecular Cancer Therapeutics|March 15, 2011
Enigmol: a novel sphingolipid analogue with anticancer activity against cancer cell lines and in vivo models for intestinal and prostate cancerHolly Symolon, Anatoliy Bushnev, Qiong Peng, et al.
Biochimica Et Biophysica Acta|October 21, 2006
Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagyWenjing Zheng, Jessica Kollmeyer, Holly Symolon, et al.
Pharmacological Research|April 5, 2003
Sphingoid bases and de novo ceramide synthesis: enzymes involved, pharmacology and mechanisms of actionDavid S Menaldino, Anatoliy Bushnev, Aiming Sun, et al.
The Journal of Biological Chemistry|December 20, 2008
Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and animalsNicholas C Zitomer, Trevor Mitchell, Kenneth A Voss, et al.
The Journal of Nutrition|March 31, 2004
Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maizeWalter F O Marasas, Ronald T Riley, Katherine A Hendricks, et al.
Cell|October 2, 2012
Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responsesNathanael J Spann, Lana X Garmire, Jeffrey G McDonald, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Applied and Environmental Microbiology|September 15, 2009
Rapid identification of Vibrio parahaemolyticus by whole-cell matrix-assisted laser desorption ionization-time of flight mass spectrometryTracy H Hazen, Robert J Martinez, Yanfeng Chen, et al.
The Journal of Biological Chemistry|September 30, 2010
Kdo2-lipid A, a TLR4-specific agonist, induces de novo sphingolipid biosynthesis in RAW264.7 macrophages, which is essential for induction of autophagyKacee Sims, Christopher A Haynes, Samuel Kelly, et al.
The Journal of Biological Chemistry|March 7, 2006
Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseasesJoungil Choi, M Cameron Sullards, James A Olzmann, et al.
Molecular Cancer|July 14, 2010
Elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometryYing Liu, Yanfeng Chen, Amin Momin, et al.
Molecular Cancer Therapeutics|March 15, 2011
Enigmol: a novel sphingolipid analogue with anticancer activity against cancer cell lines and in vivo models for intestinal and prostate cancerHolly Symolon, Anatoliy Bushnev, Qiong Peng, et al.
Biochimica Et Biophysica Acta|October 21, 2006
Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagyWenjing Zheng, Jessica Kollmeyer, Holly Symolon, et al.
Pharmacological Research|April 5, 2003
Sphingoid bases and de novo ceramide synthesis: enzymes involved, pharmacology and mechanisms of actionDavid S Menaldino, Anatoliy Bushnev, Aiming Sun, et al.
The Journal of Biological Chemistry|December 20, 2008
Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and animalsNicholas C Zitomer, Trevor Mitchell, Kenneth A Voss, et al.
The Journal of Nutrition|March 31, 2004
Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maizeWalter F O Marasas, Ronald T Riley, Katherine A Hendricks, et al.
Cell|October 2, 2012
Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responsesNathanael J Spann, Lana X Garmire, Jeffrey G McDonald, et al.
Pageof 5